Purified human IgM isoagglutinins were utilized to sensitize 51 Cr-labeled erythrocytes so as to produce a known number of complement-fixing sites. These cells were then reinfused into the erythrocyte donor. A minimum of 20 C1-fixing sites/erythrocyte were required for decreased survival. As the amount of antibody coating the erythrocytes was increased, a larger percentage was sequestered. With 80 C1-fixing sites, more than 75% of the injected erythrocytes were removed from the circulation within 10 min. In each case, the clearance pattern consisted of rapid hepatic sequestration followed by a gradual return of a portion of the erythrocytes into the circulation where they survived normally.
percentage was sequestered. With 80 Cl-fixing sites, more than 75% of the injected erythrocytes were removed from the circulation within 10 min. In each case, the clearance pattern consisted of rapid hepatic sequestration followed by a gradual return of a portion of the erythrocytes into the circulation where they survived normally.
Clearance was shown to be dependent upon activation of the classical complement pathway, since sensitized cells survived normally in hereditary angioedema patients with low levels of C4 and no detectable C2. Exposure of sensitized cells to fresh serum for 15 min led to the deposition of 550-800 C3 molecules/Cl-fixing site. Such cells were immune adherence positive, were agglutinated by anti-C3b, formed rosettes with human alveolar macrophages, and were sequestered in vivo, presumably because of the interaction of cell-bound C3b with the C3b receptor on hepatic macrophages. After exposure to heated serum as a source of the C3b inactivator, the cells were immune adherence negative, were agglutinated only by anti-C3d, did not form rosettes with macrophages, and survived normally in vivo despite, being Coombs positive. Cleavage of cell-bound C3b to C3d may explain the release phase of the IgM clearance pattern. Whereas erythrocytes coated with IgM antibody and complement were previously thought to be sequestered in the liver because of extensive membrane damage, these experiments INTRODUCTION Since the late 1940's when it first became possible to radiolabel erythrocytes and study their fate in man, there have been many investigations of autoimmune hemolytic anemia (1) (2) (3) . Interest in this condition has focused upon its importance as a model of autoimmune disease in man. Furthermore, it provides a model for the direct exploration of the consequences of cell sensitization by antibody and the mechanisms of cell destruction (2, (4) (5) (6) (7) . Early studies demonstrated that erythrocyte sensitization often leads to decreased survival and suggested that sensitization of these cells by antibody in the absence of complement activation results in splenic sequestration due to subtle antibodymediated membrane damage (4, 5, 8) . In contrast, antibodies which mediated the deposition of complement on the cell surface appeared to produce major membrane damage, and such cells were sequestered by reticuloendothelial elements of the liver (4, (6) (7) (8) (9) .
A number of clinical observations, however, questioned this simple formulation. For example, Evans et al. demonstrated that Coombs-positive erythrocytes from patients with cold agglutinin-mediated hemolytic anemia were more resistant to intravascular destruction when transfused into these patients than were normal erythrocytes (10, 11) . Furthermore, patients in clinical remission from hemolytic anemia often could be shown to have antibody and complement on their cells, as judged by tests performed with gamma and nongamma (anticomplement) Coombs sera, although their cells underwent normal survival (1, 3, 12) .
During the course of studies of the interactions of IgG and IgM antibodies and complement, it became
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clear that these two classes of antibody interacted with complement by different molecular mechanisms, and thus might be expected to produce different biological effects (13) (14) (15) . Therefore, a model for immune clearance1 and destruction of erythrocytes was established in the guinea pig to allow the function of these separate immunoglobulin classes to be assessed in molecular terms (16, 17) . In the case of IgG, there was progressive clearing of the cells from the circulation, primarily by the spleen at low levels of sensitization. Complement activation played a major role in augmenting clearance. With IgM, the pattern of clearance was entirely different. Cells coated with sufficient numbers of IgM molecules to effect clearance were rapidly sequestered by the liver. However, a major proportion of the cells were not destroyed but were returned to the circulation where they survived normally, despite the presence of antibody and complement on their surface. In this case, clearance was entirely complement dependent, and IgM could not mediate clearance in the absence of an intact classical complement pathway.
The clearance curves generated with IgM-sensitized erythrocytes in the guinea pig model did not resemble those typically noted in clearance of sensitized cells in man. However, most studies of the clearance of sensitized erythrocytes in man did not utilize highly purified immunoglobulin fractions, control for the number of sensitizing antibody molecules, nor examine the possibility of antibody elution. Thus, it was of importance to determine whether the findings in the guinea pig model were peculiar to that species or whether these findings might prove true in humans and serve to explain many of the aforementioned clinical observations.
METHODS
Study subjects. All human C3b and C3d have been previously described (27) .
After absorption with human type A erythrocytes, these regents were shown to have the proper specificity. The antiIgM sera and anti-C3 did not agglutinate erythrocytes sensitized with IgG or IgA, and the preparations did not agglutinate sensitized erythrocytes coated with the first, fourth, and second complement components. Antiglobulin (Coombs) titers were obtained with a microtiter method as previously reported (17) .
Clearance studies. This technique was performed by utilizing sterile pyrogen-free equipment and buffers. On the day of the study, 5 ml blood was drawn by venipuncture and placed in a test tube containing 0.75 ml of acid-citratedextrose solution (USP Formula A) (Fenwal Laboratories, Inc., Morton Grove, Illinois). The cells were sedimented at 1000 rpm for 5 min at 4VC and the serum and buffy coat removed. Erythrocytes were washed three times in Hanks' balanced salt solution (HBSS) and standardized spectrophotometrically to a concentration of 6.6 X 10' cells/ml. Ten AGCi of sterile sodium chromate with an average sp act of 4.9 Ag/ml (Amersham/Searle Corp., Arlington Heights, Ill.) was added dropwise with constant mixing per milliliter of standardized erythrocyte suspension and the mixture incubated for 30 min at 37°C with frequent mixing. The 51Cr-labeled erythrocytes were washed three times in HBSS and once in 0.9% saline (Abbott Laboratories, North Chicago, Ill.) before being resuspended (3.3 X 108 cells/ml) in physiologic saline. A portion of these cells were sensitized by adding dropwise with constant mixing an equal volume of the highly purified appropriate IgM antibody preparation diluted in physiologic saline. The mixture was incubated for 30 min at 37°C with frequent mixing, then washed and resuspended in normal saline (3.3 X 10' cells/ml). A 10-ml portion of this material was injected into an anticubital vein, and erythrocyte survival was determined by timed serial bleedings from the opposite arm. 11-ml samples were obtained by withdrawing blood through a 19-gauge small vein infusion set (Abbott Laboratories) into a plastic syringe lightly coated with sodium heparin (The Upjohn Co., Kalamazoo, Mich.). Exactly 10 ml was transferred to test tubes and the erythrocytes packed by centrifugation at 3,000 rpm for 10 min. The number of counts in the plasma and packed erythrocytes was obtained by utilizing a gamma scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Multiple samples were obtained during the initial 7 h of the study and daily thereafter until the rate of erythrocyte survival was determined.
Localization of the *site of sequestration of IgM-sensitized erythrocytes was established by using an organic plastic localizing whole body counter in a lead room (28) .
Calculation of erythrocyte survival. The erythrocyte survival data was analyzed, as recommended by the International Committee for Standardization in Haematology (29) . All 51Cr measurements were corrected for elution and physical decay. The recipients erythrocyte volume was calculated from the patient's weight, height, and corrected venous hematocrit, as described by Nadler, Hidalgo, and Bloch and modified by Mollison (3, 30) . Using standard dilution formulae, the zero time value was determined by dividing the total number of injected counts per minute by the calculated erythrocyte volume. The numbered counts per minute per milliliter erythrocytes was corrected to an initial value of unity, so that the data from individuals of differing size could be compared and statistically analyzed. In the control studies with labeled but unsensitized erythrocytes, the experimentally determined erythrocyte volume was within 10% of the calculated volume, and the 60-and 120-min samples were 98±-6% of the 6-and 10-min samples.
Data was plotted on semilog paper and, when appropriate, a straight line was calculated by the method of least squares in order to determine the best fitting decay curve.
Effect of in vitro incubation of IgM-sensitized erythrocytes in serum on cell survival. IgM-sensitized erythrocytes were prepared as described up to the point of injection. The cells were then sedimented and resuspended in 2 ml of fresh autologous serum/ml of the original erythrocyte solution. In some studies, the cells were incubated at 37°C for 1-2 h in the autologous fresh serum. In other studies, the cells were incubated in the fresh serum for 15 min. After 15 min, portions of erythrocytes were removed, washed once in 0.9%o saline, and resuspended in 2 vol of fresh heated (560C for 30 min) serum to 1 vol of cells for 1 or 2 h. Heating serum at 560C destroys C1 and C2 but does not destroy the C3 inactivator (31) (32) (33) . Portions of these samples were reinfused into the normal cell donors and the survival measured. Other portions were tested for antibody and C3 fragments coating the erythrocyte surface with commercial anti-IgM, anti-C3 reagents, and specific antisera against C3b and C3d fragments of C3. These samples were also tested for the ability to mediate immune serum, the cells were washed, and the number of membrane-bound C3 molecules was determined on portions of the cell preparations. These three preparations had 16,600, 24,800, and 46,800 C3 molecules/cell, respectively. Unsensitized erythrocytes exposed to fresh serum had less than 1,500 molecules of C3/cell. Thus, under these conditions, 550-800 C3 molecules were deposited on the erythrocyte membrane at each Cl-fixing site. This method of analysis of cell-bound C3 detects both C3b and its major degradation product C3d. After a 1 5-min period incubation, one would expect most of the cell-bound product to be in the form of C3b.
Between 44 and 62 (mean 53) molecules of IgM antibody/cell were sufficient to cause detectable direct agglutination. 20 and 40 IgM Cl-fixing sites could not be detected by antiglobulin reagents but were detected by anti-C3 reagents after exposure to fresh serum.
Normal erythrocyte survival. In five separate studies, the mean ti of "Cr-labeled human erythrocytes was 55.3±9.1 days, with a range of 44-71 days. Studies performed with unsensitized "Cr-labeled erythrocytes incubated in fresh normal serum, serum heated at 560C for 30 min, and 0.01 M EDTA-treated serum demonstrated comparable survival. This mean life span of 110.6 days is within the normal range and indicates normal erythrocyte survival for the labeled but unsensitized erythrocytes utilized in this study (3 (Fig. 2) . At all levels of sensitization studied, once the period of release was complete, the erythrocytes showed normal survival. Representative studies at 20 and 40 IgM Cl-fixing sites/erythrocyte are shown in Fig. 3 .
Studies with 40 IgM Cl-fixing sites/erythrocyte and with unsensitized cells were conducted in the whole body counter (Fig. 4) hepatic blood flow, rather than that of complement activation, determines the rate of removal of IgM-sensitized erythrocytes.
If erythrocytes were first exposed to fresh serum for 15 min, washed in 0.9% saline, and then resuspended in heated serum for 60 or 120 min, the sensitized erythrocytes either survived normally or showed minimally increased clearance (Table I) . Incubation of sensitized erythrocytes for 60 or 120 min in heated serum or EDTA-treated serum without prior exposure to fresh unheated serum led to no alteration in the clearance pattern.
A partial explanation for these findings was obtained by determining the nature of the complement fragment on the sensitized erythrocytes (Table I ). After 15, 60, or 120 min incubation in fresh serum, sensitized cells remained immune adherence positive and Were agglutinated by anti-C3b and -C3d. However, when sensitized erythrocytes were first exposed to fresh serum for 15 min at 37°C and then to heated serum for 60 min, the erythrocytes became immune adherence negative. These cells were strongly agglutinated by anti-C3d but weakly or not at all by anti-C3b. Effects of the prior incubation in serum on the in vivo and in vitro behavior of IgM-sensitized erythrocytes. Erythrocytes sensitized with 40 IgM Cl-fixing sites were incubated for 1 or 2 h at 37°C in autologous fresh serum. In Table I , the extent of clearance of such erythrocytes is compared to that of cells with the same level of sensitization but without prior exposure to fresh serum. Fresh serum partially protected the sensitized erythrocytes from clearance. In these studies, sensitized erythrocytes were also incubated in fresh serum for 15 min at 37°C. The configuration and magnitude of the clearance curve was identical to that seen with sensitized erythrocytes in which there was no prior serum incubation. The data suggests that the rate of patient that cells coated with cold agglutinin showed a pattern of hepatic sequestration followed by release into the circulation (34a). Evans et al. noted that erythrocytes coated with cold agglutinin would take hours to finally equilibrate after initial rapid sequestration of a large percentage of the injected cells (10, 11) . Jandl, Jones, and Castle noted a pattern of hepatic sequestration and release on one individual who received erythrocytes coated with anti-B isoagglutinins, although this was thought to be due to the fact that the cells were agglutinated at the time of injection (4) . In other studies, injection of erythrocytes coated in vitro with isoagglutinins or injection of type A or B cells into individuals with circulating isoagglutinins to the infused cell type showed a two-part clearance curve (4, (6) (7) (8) (9) . There was rapid initial hepatic sequestration or lysis of a large percentage of the injected cells followed by a period of normal or slightly decreased cell survival. The high level of erythrocyte sensitization obtained in the latter studies may account for the failure to observe the pattern of sequestration and release reported here.
Recently, utilizing animal models of immune henmolytic anemia, two groups reported a clearance pattern similar to that demonstrated herein. Brown, Lachmann and Dacie injected human cold agglutinins into rabbits and described sequestration via immune adherence to hepatic macrophages and subsequent release (35) . Schreiber and Frank injected radio-labeled erythrocytes coated with highly purified heterologous IgM antibodies into guinea pigs and showed a similar sequestration and release pattern (16) . In the guinea pig model, 60 IgM complement fixing sites were required for clearance rather than 20 sites, as observed in these studies, and the release of sequestered cells was more extensive and more rapid. Nevertheless, the similarities between the results reported here and those observed in the guinea pig model are striking. It should be emphasized that liver sequestration was not simply -a result of complement activation in the guinea pig model, since erythrocytes sensitized by complement-fixing IgG antibody were cleared by the spleen via a complementdependent mechanism. It will be of importance to determine whether complement-fixing IgG antibody leads to splenic sequestration in human beings.
Immune Clearance of Erythrocytes
At the levels of sensitization studied, accelerated clearance of IgM-coated cells was entirely complement dependent, since normal survival of the sensitized cells was observed in two angioedema patients with markedly depressed levels of C4 and C2. Patients with HANE have an intact alternate complement pathway (36) , and this finding indicates that this pathway in humans does not mediate clearance of IgM-sensitized cells. These data are in agreement with the recent work in animals, suggesting that antibodies directed at normal mammalian cell membranes are inefficient at activating the alternate complement pathway (37, 38) .
The normal survival of IgM-sensitized cells, in a setting where the classical complement pathway cannot be activated thru C3, is also in keeping with animal models of immune hemolytic anemia. Guinea pigs lacking C4 or depleted of late components (C8-9) and rabbits depleted of C8-9 were unable to clear cells heavily sensitized with IgM complement-fixing antibodies (17, 35) . That C3 was the critical component was suggested by the normal clearance of IgM-coated erythrocytes in rabbits with a total deficiency of C6 and the lack of clearance of EAC142 cells in C8-9-depleted rabbits (35) . (39) (40) (41) (42) .
These clearance data support the concept advanced in our earlier studies (17 (17) . The molecular form of C3 remaining on the surface of the erythrocytes after cleavage is termed C3d. Cells with membrane-bound C3d are immune adherence negative, although they remain Coombs positive. In the in vivo clearance studies, erythrocytes prepared as described in Methods, with C3d on their surface and with no detectable C3b, had normal survival. These same cells were bound poorly or not at all to human alveolar macrophages.' The data are entirely in keeping with the findings that Coombs-positive erythrocytes from patients with cold agglutinin (IgM) autoimmune hemolytic anemia have C3d but not C3b on their surface and survive better when reinjected into the donors than do normal erythrocytes (10, 11, 45, 46) . These circulating cells would be expected to have had C3b deposited on their surface, to have had the C3b cleaved to C3d, and therefore, to be less susceptible to destruction.
These studies in man point out a clearance pattern of IgM-coated erythrocytes consisting of rapid hepatic sequestration followed by release of a significant portion of these cells into the circulation. Such cells survive normally thereafter, probably as Coomb's-positive erythrocytes. Complement is required for the clearance of IgM-sensitized erythrocytes, and the reactivity of sensitized erythrocyte population is largely dependent on the nature of the C3 fragment bound to the erythrocyte membrane.
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